Stocks and Investing
Stocks and Investing
Fri, June 7, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Joshua Jennings Maintained (TMDX) at Strong Buy with Increased Target to $175 on, Jun 7th, 2024
Joshua Jennings of TD Cowen, Maintained "TransMedics Group, Inc." (TMDX) at Strong Buy with Increased Target from $130 to $175 on, Jun 7th, 2024.
Joshua has made no other calls on TMDX in the last 4 months.
There are 6 other peers that have a rating on TMDX. Out of the 6 peers that are also analyzing TMDX, 1 agrees with Joshua's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $95 on, Wednesday, February 28th, 2024
These are the ratings of the 5 analyists that currently disagree with Joshua
- George Sellers of "Stephens & Co." Initiated at Buy and Held Target at $151 on, Tuesday, June 4th, 2024
- Jason Mills of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $117 on, Wednesday, May 1st, 2024
- Matt O'Brien of "Piper Sandler" Reiterated at Buy with Increased Target to $120 on, Wednesday, May 1st, 2024
- Suraj Kalia of "Oppenheimer" Maintained at Buy with Increased Target to $125 on, Wednesday, May 1st, 2024
- Allen Gong of "JP Morgan" Maintained at Buy with Increased Target to $127 on, Wednesday, May 1st, 2024
Contributing Sources